Zarychta, E.; Bielawski, K.; Wrzeszcz, K.; Rhone, P.; Ruszkowska-Ciastek, B.
Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients. Int. J. Mol. Sci. 2023, 24, 13508.
https://doi.org/10.3390/ijms241713508
AMA Style
Zarychta E, Bielawski K, Wrzeszcz K, Rhone P, Ruszkowska-Ciastek B.
Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients. International Journal of Molecular Sciences. 2023; 24(17):13508.
https://doi.org/10.3390/ijms241713508
Chicago/Turabian Style
Zarychta, Elżbieta, Kornel Bielawski, Katarzyna Wrzeszcz, Piotr Rhone, and Barbara Ruszkowska-Ciastek.
2023. "Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients" International Journal of Molecular Sciences 24, no. 17: 13508.
https://doi.org/10.3390/ijms241713508
APA Style
Zarychta, E., Bielawski, K., Wrzeszcz, K., Rhone, P., & Ruszkowska-Ciastek, B.
(2023). Unraveling the Angiogenic Puzzle: Pre-Treatment sVEGFR1 and sVEGFR2 Levels as Promising Prognostic Indicators in Early-Stage Breast Cancer Patients. International Journal of Molecular Sciences, 24(17), 13508.
https://doi.org/10.3390/ijms241713508